Dong Cui Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

12/2021	Up-regulation of microRNA miR-101-3p enhances sensitivity to cisplatin via regulation of small interfering RNA (siRNA) Anti-human AGT4D and autophagy in non-small-cell lung carcinoma (NSCLC).
10/2020	Long non-coding RNA TRPM2-AS sponges microRNA-138-5p to activate epidermal growth factor receptor and PI3K/AKT signaling in non-small cell lung cancer.
1/2020	Exosomal Circ-MEMO1 Promotes the Progression and Aerobic Glycolysis of Non-small Cell Lung Cancer Through Targeting MiR-101-3p/KRAS Axis.
1/2020	Circular RNA circ-CMPK1 contributes to cell proliferation of non-small cell lung cancer by elevating cyclin D1 via sponging miR-302e.
7/2015	Clinical significance of nucleostemin and proliferating cell nuclear antigen protein expression in non-small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dong Cui Research Topics

Disease

20	Neoplasms (Cancer) 01/2023 - 07/2015
5	Neoplasm Metastasis (Metastasis) 01/2023 - 05/2018
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2021 - 07/2015
5	Lung Neoplasms (Lung Cancer) 07/2015 - 11/2011
4	Pain (Aches) 01/2023 - 01/2016
3	Esophageal Neoplasms (Esophageal Cancer) 01/2023 - 06/2021
3	Hyperalgesia 01/2022 - 01/2016
3	Inflammation (Inflammations) 12/2021 - 01/2016
3	Prostatitis 11/2016 - 01/2015
2	Diabetes Mellitus 01/2023 - 11/2022
2	Hypoxia (Hypoxemia) 01/2023 - 01/2019
2	Thrombosis (Thrombus) 03/2022 - 01/2020
2	Neuralgia (Stump Neuralgia) 01/2022 - 01/2016
2	Cognitive Dysfunction 01/2022 - 01/2021
2	Prostatic Neoplasms (Prostate Cancer) 04/2020 - 04/2015
2	Chronic Pain 01/2020 - 08/2019
2	Infertility (Sterility) 11/2016 - 04/2015
2	Autoimmune Diseases (Autoimmune Disease) 11/2016 - 04/2015
2	Carcinogenesis 01/2015 - 11/2011
1	Humeral Fractures 03/2024
1	Distal Femoral Fractures 12/2023
1	Wounds and Injuries (Trauma) 12/2023
1	Bipolar Disorder (Manic Depressive Psychosis) 11/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023
1	Cerebral Cortical Thinning 01/2023
1	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2023
1	Hyperglycemia 01/2023
1	Kidney Calculi (Kidney Stone) 10/2022
1	Hemorrhage 10/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022
1	Diarrhea 12/2021
1	Epilepsy (Aura) 01/2021
1	Renal Artery Obstruction (Renal Artery Stenosis) 01/2021

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2011
8	PolymersIBA 01/2023 - 06/2017
5	Small Interfering RNA (siRNA)IBA 12/2021 - 11/2011
4	Messenger RNA (mRNA)IBA 01/2016 - 11/2011
3	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2018
3	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2013 - 11/2011
2	Polymethyl Methacrylate (Sol)IBA 03/2024 - 12/2023
2	TitaniumIBA 12/2023 - 11/2022
2	Therapeutic UsesIBA 01/2023 - 11/2017
2	Ion Channels (Ion Channel)IBA 01/2023 - 08/2019
2	Immunologic Factors (Immunomodulators)IBA 01/2023 - 12/2022
2	Singlet OxygenIBA 12/2022 - 01/2021
2	Atorvastatin (Lipitor)FDA Link 01/2022 - 01/2021
2	oxidized low density lipoproteinIBA 01/2022 - 01/2021
2	Analgesics (Analgesic Drugs)IBA 01/2022 - 01/2016
2	C-Reactive ProteinIBA 01/2022 - 12/2021
2	LipidsIBA 01/2022 - 01/2021
2	MicroRNAs (MicroRNA)IBA 12/2021 - 10/2020
2	Long Noncoding RNAIBA 12/2020 - 10/2020
2	Circular RNAIBA 01/2020 - 01/2020
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 11/2019 - 01/2019
2	CateninsIBA 05/2018 - 01/2016
2	AntibodiesIBA 11/2016 - 04/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2015 - 04/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2023
1	tektinsIBA 01/2023
1	Complement System Proteins (Complement)IBA 01/2023
1	Galectin 3 (LGALS3)IBA 01/2023
1	Ribosomal Proteins (Ribosomal Protein)IBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	KinesinsIBA 01/2023
1	CytochromesIBA 01/2023
1	verubecestatIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	Amyloid beta-PeptidesIBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 12/2021
1	Nucleic AcidsIBA 12/2021
1	ProcalcitoninIBA 12/2021
1	Serum AlbuminIBA 12/2021
1	C-terminal binding proteinIBA 06/2021
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 06/2021
1	snake venom protein C activatorIBA 01/2021
1	poly(lactide) (polylactic acid)IBA 01/2021
1	EnzymesIBA 01/2021
1	Cathepsin BIBA 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	KynurenineIBA 01/2021
1	Proteolysis Targeting ChimeraIBA 01/2021
1	LDL CholesterolIBA 01/2021
1	Radioisotopes (Radionuclides)IBA 01/2021
1	Tumor Biomarkers (Tumor Markers)IBA 01/2021

Therapy/Procedure

8	Therapeutics 01/2021 - 07/2015
5	Immunotherapy 01/2023 - 01/2019
2	Debridement 12/2023 - 01/2023
2	Esophagectomy 01/2023 - 01/2022
2	Length of Stay 10/2022 - 01/2022
2	Stents 03/2022 - 01/2020
2	Transcranial Magnetic Stimulation 01/2022 - 01/2020
2	Phototherapy (Light Therapy) 01/2021 - 01/2019
2	Photochemotherapy (Photodynamic Therapy) 11/2019 - 01/2019
1	Percutaneous Nephrolithotomy 10/2022
1	Aftercare (After-Treatment) 01/2022
1	Drug Therapy (Chemotherapy) 12/2021
1	Autologous Transplantation 01/2021
1	Cardiopulmonary Resuscitation (CPR) 01/2021